AA Amyloidosis Associated With Systemic-Onset Juvenile Idiopathic Arthritis

被引:8
|
作者
Saha, Abhijeet [1 ]
Chopra, Yogiraj [1 ]
Theis, Jason D. [2 ]
Vrana, Julie A. [2 ]
Sethi, Sanjeev [2 ]
机构
[1] PGIMER & Associated Dr RML Hosp, Div Pediat Nephrol, New Delhi, India
[2] Mayo Clin, Dept Lab Med & Pathol, Div Anat Pathol, Rochester, MN 55902 USA
关键词
AA amyloid; systemic-onset juvenile idiopathic arthritis; mass spectrometry; proteomics; RHEUMATOID-ARTHRITIS; MASS-SPECTROMETRY; RENAL AMYLOIDOSIS; STATISTICAL-MODEL; LEFLUNOMIDE; METHOTREXATE; DISORDERS; DIAGNOSIS; DATABASE;
D O I
10.1053/j.ajkd.2013.02.377
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report a 12-year-old boy with nephrotic syndrome due to renal AA amyloidosis. The AA amyloidosis was associated with a 3-year history of systemic-onset juvenile idiopathic arthritis. The presence of serum amyloid A protein was confirmed by laser microdissection of Congo Red-positive glomeruli and vessels followed by liquid chromatography and tandem mass spectrometry; this analysis excluded hereditary and familial amyloidosis. Aggressive management of the systemic-onset juvenile idiopathic arthritis resulted in improvement in clinical and laboratory parameters. The case represents an unusual cause of nephrotic syndrome in children. Early diagnosis of renal amyloidosis and management of systemic-onset juvenile idiopathic arthritis is paramount to preventing progression of kidney disease. Am J Kidney Dis. 62(4):834-838. (C) 2013 by the National Kidney Foundation, Inc.
引用
下载
收藏
页码:834 / 838
页数:5
相关论文
共 50 条
  • [41] Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis?
    Cem Gabay
    Nature Clinical Practice Rheumatology, 2008, 4 : 572 - 573
  • [42] Remission of Refractory Systemic-Onset Juvenile Idiopathic Arthritis After Treatment With Siltuximab
    Leurs, Amelie
    Launay, David
    Terriou, Louis
    Hatron, Pierre-Yves
    Quartier, Pierre
    Hachulla, Eric
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 (04) : E40 - E42
  • [43] Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab
    Takezaki, Shunichiro
    Okura, Yuka
    Ichikawa, Mizuho
    Suzuki, Daisuke
    Ohshima, Junjiro
    Kaneda, Makoto
    Cho, Yuko
    Yamada, Masafumi
    Kawamura, Nobuaki
    Iguchi, Akihiro
    Kobayashi, Ichiro
    Ariga, Tadashi
    MODERN RHEUMATOLOGY, 2012, 22 (04) : 621 - 624
  • [44] Positron Emission Tomography Assessment Of Children With Systemic-onset Juvenile Idiopathic Arthritis
    Kanetaka, Taichi
    Nozawa, Tomo
    Nishimura, Kenichi
    Kikuchi, Masako
    Sato, Tomomi
    Sakurai, Nodoka
    Hara, Ryoki
    Yamazaki, Kazuko
    Yokota, Shumpei
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S94 - S94
  • [45] Characterization of microbiota in systemic-onset juvenile idiopathic arthritis with different disease severities
    Dong, Yan-Qing
    Wang, Wei
    Li, Ji
    Ma, Ming-Sheng
    Zhong, Lin-Qing
    Wei, Qi-Jiao
    Song, Hong-Mei
    WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (18) : 2734 - 2745
  • [46] Treatment of systemic-onset juvenile arthritis with canakinumab
    Peitz, Joachim
    Horneff, Gerd
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2015, 7 : 23 - 31
  • [47] METHOTREXATE-INDUCED VASCULITIS IN A CHILD WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
    Markham, Rebecca
    Whittam, Lindsay
    Armstrong, Janette
    Wilkinson, Nick
    Williamson, Lyn
    RHEUMATOLOGY, 2017, 56 : 64 - 65
  • [48] Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis
    Zeng, Hua-Song
    Xiong, Xiao-Yan
    Wei, Yan-Dan
    Wang, Hong-Wei
    Luo, Xiao-Ping
    WORLD JOURNAL OF PEDIATRICS, 2008, 4 (02) : 97 - 101
  • [49] IL-6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis
    S Yokota
    T Miyamae
    T Imagawa
    M Mori
    Arthritis Res Ther, 5
  • [50] Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis?
    Gabay, Cem
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (11): : 572 - 573